Medacta Group SA
OTC:MEDGF

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
OTC:MEDGF
Watchlist
Price: 83.91 USD Market Closed
Market Cap: $1.7B

Wall St Price Targets

MEDGF Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MEDGF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDGF is 106.51 USD with a low forecast of 94.1 USD and a high forecast of 119.85 USD.

Lowest Forecast
Price Target
94.1 USD
12% Upside
Average Forecast
Price Target
106.51 USD
27% Upside
Highest Forecast
Price Target
119.85 USD
43% Upside
Medacta Group SA Competitors:
Price Targets
GWH
ESS Tech Inc
172% Upside

Revenue
Forecast

14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 10%.

Gross Profit
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.

Operating Income
Forecast

11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 7 years is 11%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 8 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDGF's stock price target?
Price Target
106.51 USD

According to Wall Street analysts, the average 1-year price target for MEDGF is 106.51 USD with a low forecast of 94.1 USD and a high forecast of 119.85 USD.

What is the Revenue forecast for Medacta Group SA?
Projected CAGR
10%

Over the last 8 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 10%.

What is the Gross Profit forecast for Medacta Group SA?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for Medacta Group SA?
Projected CAGR
11%

Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 7 years is 11%.

What is the Pre-Tax Income forecast for Medacta Group SA?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Medacta Group SA?
Projected CAGR
11%

Over the last 8 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett